Covid-19 Vaccines and Allergy: Let’s Talk


SPEAKERS:

Lori Connors

Lori Connors

MD, MEd, FRCPC

Lori Connors is certified by the Royal College of Physicians and Surgeons of Canada in both Allergy/Clinical Immunology and Internal Medicine. She has been in practice since 2010. Her time is spent mainly at Halifax Allergy and Asthma Associates as an allergist and immunologist. The remainder of her time is spent practicing internal medicine at the QEII Health Sciences Centre.

Karina Top

Karina Top

Dr. Karina Top is pediatric infectious disease physician and an Associate Professor of Pediatrics and Community Health & Epidemiology at Dalhousie University in Halifax. Dr. Top is the Principal Investigator of the Canadian Immunization Research Network’s Special Immunization Clinic Network. Her research focuses on management of patients with previous adverse events following immunization, and vaccine safety and effectiveness in immunocompromised patients.

Kyla Hildebrand

Kyla Hildebrand

MD, FRCPC, MScCH, (HPTE)

Dr. Kyla Hildebrand is a Pediatric Clinical Immunology and Allergy specialist and clinician educator at BC Children’s Hospital in Vancouver, Canada. She is a Clinical Associate Professor in the Department of Pediatrics and Division of Allergy & Immunology at the University of British Columbia, an investigator at the BC Children’s Hospital Research Institute and the director of the Pediatric Clinical Immunology and Allergy Residency Training Program at UBC. Dr. Hildebrand has been a member of the Special Immunization Clinic network investigating adverse reactions following immunization since 2014. In 2018, Dr. Hildebrand was selected as a voting member on the National Advisory Committee for Immunization, a national advisory committee of experts to provide ongoing and timely medical, scientific and public health advice. Her research focus is knowledge translation in the areas of prevention of food allergy, inborn errors of immunity and vaccine allergy.

Gaston de Serres

Gaston de Serres

MD, PhD

Dr Gaston De Serres obtained his MD and his PhD in Epidemiology at Laval University where he is currently full Professor of Epidemiology. Dr. De Serres is also currently Medical Epidemiologist at the Institut National de santé publique du Québec (INSPQ) where he is the Medical Chief of the Immunization Scientific Unit. He is the lead expert in charge of the influenza vaccination program and of vaccine safety issues. He is a member of the Quebec Immunization Committee since 1999 and was a member of the National Advisory Committee on Immunization (NACI) between 1997 and 2004. He is a member of the Canadian National Working Group on measles and rubella elimination. He is also a member of the Quebec Vaccine Adverse Event Surveillance Group (ESPRI) since 1996. He has published more than 220 peer-reviewed articles including many vaccine safety studies.

LEARNING OBJECTIVES

By the end of this session participants will be able to:

  • Outline the vaccines available for COVID-19 in Canada/in pipeline
  • Discuss the current allergy issues related to Covid-19 vaccines
  • Explain vaccine adverse event reporting in Canada and review available data on Covid-19 vaccine safety
  • Communicate with health care providers and patients about allergy concerns and Covid-19 vaccines

“This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and approved by Canadian Society of Allergy and Clinical Immunology.”

For members only
Register Now »


This Webinar is brought to you with the support of our esteemed partners: